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Abstract: Cassava is a major staple that supplies more than 50% of daily energy to more than 200 million persons in 
sub-Saharan Africa (SSA). Cassava roots are known to be low in micronutrients such as vitamin A, iron, and zinc. 
Micronutrient deficiencies threaten the lives of millions of poor households and those located in remote rural areas of 
SSA often not targeted by fortification programmes. This paper presents results from an ex-ante evaluation of nutrition 
and health benefits of increased vitamin A status of cassava roots through biofortification for at-risk-target-groups 
using the disability-adjusted life years (DALYs) approach. Results showed that Vitamin A deficiency (VAD) causes an 
annual loss of about 553,000 years of “healthy” life in Nigeria with children constituting more than forty percent. 
Biofortified cassava would reduce VAD by 4.42%, 11.73%, and 3.14% for children, pregnant women, and lactating 
women respectively in the pessimistic scenario. Results for the optimistic scenario are 28.79%, 76.39, and 20.45% 
respectively. The biofortification of cassava roots would result in annual gains of about 33,000 years of “healthy”life 
and avert 166 child deaths per year for the pessimistic scenario and about 220,000 years life and 1272 child deaths per 
year for the optimistic scenario. In economic terms, such a programme would bring gains amounting to about $10 
million per year, which Biofortification, DALYs, Economics, Health, corresponds to an internal rate of return (IRR) as 
high as 92.4% in the pessimistic scenario. Results in the optimistic scenario are about $63 million per year and an IRR 
of 165.3%. A research and development effort aimed at the biofortification of cassava roots is a powerful strategy in the 
fight against hidden hunger from micronutrient deficiencies, which African governments at the national and local 
levels, and international investors should support to improve the standard of living of the people in SSA.  




Cassava is considered the most important root crop, which is grown in over 90 countries. It serves as a staple food for 
more than 500 million people worldwide. According to Scott et al. (2000), 172 million tonnes of cassava was produced 
worldwide in 2000. Africa accounted for 54%, Asia for 28%, and Latin America and the Caribbean for 19% of the total 
world production. Sub-Saharan Africa (SSA) produced more than 85  million  MT yearly—about half of global 
production (FAO, 2003). This amount is about double sub-Saharan Africa’s production of maize and almost triples its 
combined production of sorghum and millet.  
 
Cassava provides food and livelihood for many resource poor and rural households in the developing world. The 
various forms in which cassava is consumed include raw, boiled, cooked and fried slices, flakes, fermented, flour, 
macaroni, fufu, and gari among others. Cultivated in many SSA countries, cassava is an especially important food crop 
in Nigeria, the Democratic Republic of the Congo, Tanzania, Ghana, Mozambique, Uganda, Madagascar, Angola, Côte 
d’Ivoire, Cameroon, Benin, and Kenya. However, many people in countries of sub-Saharan Africa are undernourished 
with high levels of micronutrient malnutrition threatening the lives of millions of poor households especially those 
located in remote rural areas often not targeted by fortification and pharmaceutical supplementation programmes.  
Nigeria, with a population of more than 110 million and an annual growth rate of about 2.83% has a very low annual 
per capita income of US$290 in the 2001 period (World Bank, 2003). This, coupled with the high rate of inflation of 
about 27% in the economy has resulted in increased poverty among the people with more than 9 million people 
undernourished and consequently deficient in essential micronutrients (such as vitamin A, iron, and zinc) which are 
required for healthy growth and development (World Bank, 1994). Vitamin A deficiency (VAD) is a leading cause of 
early childhood death and a major risk factor for pregnant and lactating women with about 3 million African children 
under the age of five suffering from blindness as a result of VAD (UNACCSN, 1994). A recent study shows that 29.5% 
of children less than five years, 8.8% of pregnant women and 4.1% of lactating women are found deficient in VA 
(Maziya-Dixon et al., 2004). The condition can kill directly, but also causes different acute and chronic health 
problems, such as weakening the immune system and leaving its victims susceptible to deadly diseases like measles, 
malaria and diarrhoea (West and Darnton-Hill, 2001).     
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In the past, food fortification and pharmaceutical supplementation were the only known strategies used to reduce the 
health burden associated with micronutrient deficiencies. These approaches however, require continuous huge 
investments, with benefits limited to the few number of people who have access to and who could afford them, often in 
the urban centers. Further research revealed that improving the micronutrient content of major staples produced and 
consumed by rural and resource-poor households would go a long way in reducing the level of micronutrient deficiency 
among different categories of people in SSA. Recent efforts include the introduction of biofortified crops – varieties 
bred for increased mineral and vitamin content – through the biofortification challenge programme (known as 
HarvestPlus), which involves breeding staple food crops for enhanced micronutrient content. It is a new paradigm for 
agriculture and a tool for improving human health. Biofortification will complement existing strategies and provide a 
sustainable and low-cost intervention of reaching people with poor access to markets and formal health care systems 
(HarvestPlus 2004). This is aimed at improving the nutrition and health status of the undernourished in the developing 
countries (Alexander et al., 2004). Nigeria with 33 million tonnes of cassava roots in 2003 (the world's largest 
producer) would benefit greatly from such a biofortification programme. 
 
However, as biofortified crops are not yet available, and in order to ascertain the extent of the nutrition and health 
benefits of a biofortification programme, this paper uses an ex-ante approach to evaluate the nutrition and health 
benefits of increased vitamin A status of cassava roots through biofortification for at risk target groups in Nigeria using 
the disability-adjusted life years (DALYs) approach. The paper is divided into three main sections after the 




Study area and data collection  
 
The study covered Nigeria as a whole and is based mainly on secondary data.  
Data collected include demographic, food intake, beta-carotene content in food, bio-conversion rate to vitamin A (VA), 
and health consequences of VAD. Demographic data (population composition and mortality rate) were obtained from 
UNICEF (2003) and Nigeria Ministry of Health (1999).  The food consumption pattern (cassava intake, other food 
items) of the target group was generated from the database on 24-hour dietary recall undertaken during the Nigeria 
Food Consumption and Nutrition Survey (Maziya-Dixon et al., 2004). Data were validated from a 24-hour dietary 
recall among pregnant women, lactating women and their babies, as well as children of 5 years of lower in three 
communities of southwest Nigeria. The choice of these locations was based on criteria such as being major cassava 
producing locations where cassava consumption provides more than 50% energy/day for the people, and where 
secondary information on previous food studies could be obtained. The findings from the three communities were 
adapted to address the general food consumption patterns in Nigeria. Tables for food composition from various sources 
(Oguntona and Akinyele, 1995; Pennington, 1994; Prosper, 1987; West and Poortvliet, 1983; and FAO/USDHEWPHS, 
1968) were used to calculate the supply of VA from food intake by each target group. Cassava breeders and economists 
provided information on the VA content of cassava (before and after bio-fortification) and on the duration and costs 
related to the development and diffusion of BC.  The bio-conversion rate into VA was from Zimmermann and Qaim 
(2004). Data on prevalence/incidence rates of and number of people affected by VAD, disability weights and mortality 
rates, and health consequences of VAD were also collected from various sources (Maziya-Dixon et al., 2004; 
UNSSCN, 2004; UNICEF, 2003; West and Darnton-Hill, 2001; Murray and Lopez, 1996; World Bank, 1994; and 
Brenzel, 1993) and confirmed by local nutritionist and health experts.  
 
Data analysis 
Data were analysed with descriptive statistics and the DALYs techniques. Descriptive statistics involve the use of 
percentages and means to summarize major parameters in the study. The social costs associated with health problems 
are quantified using the DALYs technique. The social costs are expressed in years of “healthy” life lost, and are 
calculated on an annual basis. DALYs measure both the disease and death condition resulting from a micronutrient 
deficiency, and the total number of DALYs lost, following World Bank (1993) and Murray and Lopez (1996), is 
expressed as:  
DALYsLost=YLL + YLDtemp. + YLDperm.…………………………………… (1) 
Where, YLL is the number of years of life lost due to mortality, and YLDtemp and YLDperm are years of life lost due 
to temporary and permanent disability respectively. In order to add up disability (temporary and permanent) and death, 
the sum of YLD are weighted according to the level of “severity” or “disability” ranging from 0 to 1, with zero 
connoting perfect health condition while 1 is a health status equal to death. Thus, based on the different levels of 
severity of disease types among targeted groups in a population, the complete DALYsLost model is expressed as: 
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This model follows from Murray (1996), Alexander et al. (2004) and Zimmermann and Qaim (2004). Σj is the sum for 
all target group j, Tj is the number of people in target group j (where j = children, pregnant women or lactating women). 
Mj is the mortality rate associated with VAD, Lj is the average remaining life expectancy in the same group, r is the 
discount rate of future life, Iij is the incidence rate of temporary disease I in group j, Dij is the corresponding disability 
weight, dij is the duration of the temporary disease, and k represents conditions for the permanent disease.   
 
It is assumed that VAD related diseases and associated costs would be reduced if BC were consumed regularly. This 
can be accounted for by a decrease in the prevalence rates of these diseases in each target group. Following Brenzel 
(1993), the reduced prevalence rates can be calculated as:  
[[ ]P E Pn ij j ij C × × − = ) 1  …………………………………………………..…. (3) 
Where the new prevalence rate of disease i (or incidence rate of disease k) in group j (Pnij) is a function of the initial 
prevalence rate (Pij), the group-specific efficacy rate (Ej) which is a function of the characteristics of BC, and the 
technology coverage rate (C) of BC which depends on its accessibility and acceptance. The new prevalence rates are 
now inserted into equation (2) to obtain the number of DALYsLost with BC.  
 
The health impact of BC is measured by computing the difference between the numbers of DALYsLost “without BC” 
and the number of DALYsLost “with BC”. The difference is expressed as the number of “disability-adjusted life years” 
gained (i.e. DALYs gained). DALYs gains are computed under two scenarios: pessimistic and optimistic. Parameters 
for both scenarios under the original assumptions are shown in Table 1. A sensitivity analysis was conducted on some 
key parameters such as post harvest losses, technology coverage rate, and the amount of beta-carotene in BC based on 
the optimistic scenario in the original assumptions (Table 1). The economic implications of DALYs gained from BC 
are assessed on the basis of the cost per DALY as recommended by World Bank (1994).  
 
Results and Discussion 
 
The effect of VAD among the target population studied is shown in Table 2. The mortality rate is highest among 
children, particularly infants and deaths associated with VAD are very important. Of all the children below 5 years, 
infants mortality account for 60.1%. The average age at which blindness (a permanent disability resulting from VAD) 
sets in among children is about 2.5 years (Newman 1993). According to this author, breast-fed infants have body stores 
of VA, which prevents eye symptoms unless depleted. Corneal xerophthalmia (that leads to blindness) is usually high 
between the age of 2 and 3 years for children and thirty years for pregnant and lactating women (Newman, 1993; West 
and Darnton-Hill, 2001). This implies that intervention programmes aimed at reducing the mortality rate associated 
with VAD among children should be targeted to pregnant and lactating women through extended periods of exclusive 
breastfeeding. Thus, if BC were consumed regularly the same way cassava is currently being consumed by resource 
poor rural households, it would help to alleviate this health problem. 
 
Both clinical and sub-clinical manifestations of VAD are reported in Table 3. Serum retinal levels are accounted for by 
sub-clinical VAD, while clinically evident ocular manifestation of VAD (xerophthalmia) constitutes the clinical 
manifestations. This includes night blindness, Bitot’s spot, corneal ulceration, corneal scars, and blindness. Sub-clinical 
VAD is most predominant in children of less than 5 years with the highest prevalence rate, and accounts for 91.0% of 
the number of people affected in the three target groups. Pregnant and lactating women respectively account for 6.4% 
and 2.6% of the sub-clinical VAD. Night blindness is the most important clinical manifestation, followed by Bitot’s 
spot, corneal ulceration, blindness, and corneal scars in that decreasing order of importance. Again children of les than 
5 years old, are the most affected compared to pregnant and lactating women.  
 
Estimates of DALYs lost due to VAD without BC is shown in Table 4. The total DALYs lost annually due to VAD 
related mortality and disability conditions is 1,403,609.  Children suffer most: DALYs lost represent 78% of the total 
while women account for 11% for each target group. Mortality constitutes 67% of all the DALYs lost while loss due to 
disability accounts for 6% temporal and 26% for permanent. Adding loss due to mortality and that due to permanent 
disability makes the social impact of VAD even greater. Persons affected by a permanent disability or death cannot 
contribute fully to the economy of a country. These high consequences of VAD in Nigeria constitute an additional 
reason for a new strategy to fight VAD through biofortification. Children should be the major beneficiaries of the new 
biofortification programmes of crops, in particular to address the consequences on death. Out of the total DALYs lost 
for children, the proportion due to mortality accounts for 86.1%. For the children to benefit more from this new 
strategy, they need to eat more of the new cassava. Educational campaigns will be needed to increase the awareness 
among mothers in the choice of the type of cassava to be fed to their kids. In monetary terms, the total DALYsLost per 
annum amounting to 1,403,609 is about US$1,403.6 million. Thus, the cost of VAD is quite huge and requires 
immediate strategies of intervention. 
 
With BC, annual gains of 98,770 years of healthy life are estimated in the pessimistic scenario (Table 5). Children 
account for 49.6% of this estimate, while pregnant and lactating women account for 26.7% and 23.7% respectively. 
Reduced disability accounts for 13.9% of the total DALYs gained among children while all gains for pregnant and   4
lactating women were due to reduced disability. About 57.3% of the total estimated DALYs gained in the pessimistic 
scenario is due to reduced disability, while 42.70% accounts for reduced mortality. Cassava biofortification can avert a 
total of 1,651 child deaths per year in the pessimistic scenario. In monetary terms, the health gain is about US$98.8 
million per year, corresponding to an internal rate of return (IRR) of as high as 185.9% (Bamire et al., 2004). In the 
optimistic scenario, the biofortification of cassava can result into annual gains of about 295,539 years of healthy life, 
with children, pregnant and lactating women accounting for 59.1%, 21.0% and 19.8% respectively. About 49.1% of the 
health gain is attributed to disability, while reduced mortality accounts for about 50.9%. The biofortification of cassava 
roots can avert 5,886 child deaths in the optimistic scenario, which translates into an annual gain of US$295.5 million 
with a high IRR of about 243.8% (Bamire et al., 2004).  
The potential annual benefits correspond to the reduction in the health burden of about 7% for the pessimistic scenario 
and 31% for the optimistic scenario. The investments required to make that reduction in the social cost of VAD lead to 
high economic returns between about $100 m and $300 m annually depending on the type of scenarios. The 
corresponding high IRRs indicate that investment in the biofortification of cassava is indeed very profitable. This 
shows that tremendous health gains could be achieved through BC roots. 
 
Although the health and nutrition benefits are quite high to justify an investment in the biofortification of cassava roots, 
the above results also show the new cassava under the original assumptions would not be able to fully resolve the social 
costs associated with VAD. 
 
A sensitivity analysis was conducted on key parameters to define the minimal conditions under which the new BC will 
fully address the estimated social costs of VAD for the cassava consumers in Nigeria. Three separate strategies 
emerged.  
 
The first is on the reduction of post-harvest losses to 22%. Maintaining other parameters constants under the optimistic 
scenario (i.e. beta-carotene at 15µg/g and technology coverage rate at 40%), the reduction in post-harvest losses to 22% 
will eliminate the health burden and result in a bonus of 4445 DALYs. Reduction of post-harvest losses to 22% would 
require the consumption of cassava roots as fresh and boiled only. This would be a complete change in the consumption 
habits of the target population, which is unlikely to happen because cassava is usually eaten processed into lafun, fufu, 
eba, gari in Nigeria. Food technologists should come up with new processing methods that retain most of the VA in the 
processed cassava products.  
 
The second strategy would be to increase the beta-carotene content to 58.5µg/g, other parameters kept constants under 
the optimistic scenario (i.e. post-harvest losses at 80% and technology coverage rate at 40%). This amount should be 
the target for breeders through conventional breeding and/or engineering. The potentials for acceptance of the new 
cassava are higher because consumers will still use cassava in the known forms as lafun, fufu, eba, gari as long as the 
new BC meets other consumers’ preferences such as color, taste, stickiness, starch content, yield, resistance to pests 
and diseases, etc. Increasing the beta-carotene to a minimum of 58.5µg/g will eliminate the health burden and also 
result in a bonus of 4445 DALYs. The only issue from this second strategy as a stand-alone strategy is that 80% of the 
gains in beta-carotene content from the breeding programmes are lost. In other words, consumers have to waste 4/5th of 
the beta-carotene generated that supplies more than 50% of daily energy and use only 1/5
th of it.  
 
The third strategy is a simultaneous change that result in the reduction of post-harvest losses, an increase in the beta-
carotene content, and expansion in the use of the technology by both producers and consumers. Results show post-
harvest losses of 66%, beta-carotene of 35µg/g and technology coverage of 45% would completely eliminate the social 
costs due to VAD (Table 6). Other alternative combinations could be tested. By all means, increasing the total coverage 
alone to 100% could not totally reduce the health burden under the original optimistic scenario, as it was the case for 
the first and second strategy. Implementing this third strategy implies that an integrated approach that brings together 
food technologists, cassava breeders, extension services, economists, etc. will totally pay for the losses due to VAD. 
Thus, a multi-facet research and development effort aimed at the biofortification of cassava roots is imperative to 
reduce the growing trend of death cases and disabilities resulting from micronutrient deficiencies in SSA. 
 
Summary and Conclusion 
 
This paper evaluated the nutrition and health benefits of cassava biofortification among children, pregnant and lactating 
women in Nigeria using the DALYs approach. Results showed that more than 1.4 million years of healthy life are lost 
annually due to VAD amounting to a huge monetary loss of about US$1,403.6 million. The conservatively estimated 
annual health gains associated with BC roots range between 98,770 and 295,539 years of healthy life respectively in the 
pessimistic and optimistic scenarios depending on the underlying assumptions. This translates into an internal rate of 
return as high as between 185.9% and 243.8%. A large positive health effect is obtained with increasing levels of 
coverage of the technology and beta-carotene content, and reducing post harvest losses. The results imply that deaths 
and related health effects associated with VAD among resource poor households in developing countries would be 
substantially reduced with the biofortification programme, particularly through an integrated approach. Thus, a research 
and development effort aimed at the biofortification of cassava roots is imperative for African governments at the   5
national, state and local levels as well as international investors to embark upon to reduce the growing trend of death 
cases resulting from VAD in SSA. This would help to meet the food and nutrition challenges of the people and improve 
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Table 1: Key parameters used in computing DALYs “with” biofortified cassava  
Original Assumption   Parameter 
Pessimistic Scenario  Optimistic Scenario 
Post-harvest losses (%)  90.0  80.0 
Technology coverage rate (%)  30.0  40.0 
Amount of beta-carotene (µg/g)  10  15 
Bioconversion rate to VA (x:1)  12  12 
Cost per DALYs (US$)  1,000  1,000 
Source: West and Darnton-Hill, 2001; World Bank, 1994; Cassava Breeder and  




 Table 2: Mortality due to vitamin A deficiency among the target population  
 
Group Population  Mortality  rate 
Mortality due 
to VAD 
Total Deaths # Deaths from 
VAD 
Average age of 
onset of 
blindness  
    Infants  8,005,300  11.0%  2.53%  880,583 22,279    
    Children  12,062,700  7.3%  1.68%  880,577 14,794    
Children (<5 
years)  20,068,000  18.3% 
   1,761,160 37,072  2.5 
Pregnant 
women  4,702,000  0.80% 
 
37,616 0  30 
Lactating 
women  4,176,000  0.80% 
 
33,408 0  30 





Table 3: Prevalence rates and number of people affected by VAD 
 
Children (<5 years)  Pregnant women  Lactating women 
Clinical manifestation  Disability 

















 Sub-clinical VAD  0.00  29.50  5,920.06  8.80  413.78  4.10  171.22 
 Night blindness  0.15  0.69  138.47  0.86  40.44  0.77  32.16 
 Bitot’s spot  0.25  0.17  34.12  0.58  27.27  0.60  25.06 
 Corneal ulceration   0.50  0.09  18.06  0.43  20.22  0.43  17.96 
 Corneal scars  0.50  0.00  0.00  0.21  9.87  0.26  10.86 
 Blindness   0.50  0.05  9.03  0.32  15.05  0.34  14.41 
Source: Maziya-Dixon et al., 2004; UNSSCN, 2004; UNICEF, 2003; West and Darnton-Hill, 2001; Murray & Lopez, 
1996; World Bank, 1994; Brenzel, 1993; Nutritionist (personal communication)   7
Table 4: DALYs lost due to vitamin A deficiency without biofortified cassava 
Loss    Lost  Children  Pregnant Women Lactating Women  Total 
 Due to mortality   YLL 947,324 0  0 947,324 
 Due to temporary disability  YLD temp  37,761 27,515  25,116 90,392 
 Due to permanent disability  YLD perm  115,381 127,974  122,538 365,893 
 Total due to disability   YLD Total  153,142 155,489  147,654 456,285 
 Total   DALY Lost 1,100,466  155,489  147,654  1,403,609 
 In monetary terms (million US$)  1,100.5 155.5  147.7 1,403.6 
YLL= years of life lost; YLD temp = years of life due to temporary disability; YLD perm = years of life due to 
permanent disability; YLD Total = years of life due to disability  
Source: own calculations 
 
Table 5: Potential annual benefits of biofortified cassava (DALYs gained) based on the original 
assumptions 
Pessimistic Scenario  Optimistic Scenario  Gain 




Total  Children  Pregnant 
Women 
Lactating 
Women  Total 
Due to 
reduced 
mortality  42,178  0 0  42,178  150,406  0 0  150,406 
Due to 
reduced 
disability  6,818 26,330 23,444  56,592  24,314  62,165 58,654  145,133 
 
Total 












Note: *Internal Rate of Return (IRR) = 185.9%; **IRR = 243.8%  
Source: own calculations 
 
 




Table 6: Impact of key parameter variations on DALYs with biofortified cassava under the optimistic 
scenario  
Parameter DALYs  gained  with BC  Percent reduction in health 
burden
1  
Original assumptions   295,539  21.1 
Post-harvest losses (22%)  1,408,054  100 
Technology coverage rate (100%)  736,184  52.5 
Amount of beta-carotene (58.5µg/g)  1,408,054  100 
Simultaneous changes in the three 
parameters  1,432,495 102.1 
 
1DALYs lost due to VAD without BC is 1,403,609, Source: own calculations 
 